Breast Cancer Coordinated Care (BC3) 2026

Breast Cancer Coordinated Care (BC3) 2026 returns to Washington, D.C., as the definitive three-day symposium for multidisciplinary breast cancer coordinated care, bridging the gap between breast and plastic surgery, oncology, radiology, radiation oncology, pathology, physical therapy, occupational therapy, social work, nursing, and all fields related to breast cancer coordinated care. By evaluating successful care models and innovative approaches from major centers across the United States, this course tackles the field’s most pressing controversies and moves to deconstruct siloed treatment approaches. Attendees will engage in high-level discussions on cutting-edge diagnostic tools and novel management strategies, with the collective goal of developing standardized, evidence-based protocols that redefine the standard of breast cancer coordinated care.

1. Integrate an Interdisciplinary Care Model: Identify the unique roles and responsibilities of each healthcare team member to foster a seamless, team-based approach for both the prevention and treatment of breast cancer.
2. Enhance Patient Communication: Effectively explain the management of side effects from various breast cancer treatments to patients, ensuring better adherence and quality of life during survivorship
3. Redefine the Nipple Sparing Mastectomy: Current evolution of nipple sparing mastectomy can support direct to implant reconstruction with minimal complication profile. This leads to improvement in quality of life, decreased surgical burden, and cost savings for the health system
4. De-escalate Surgical Treatment: Identify current indications for radiation therapy and explain its evolving role in allowing for the de-escalation of more invasive surgical procedures.
5. Master Axillary Management: Describe evidence-based options for the management of a positive sentinel lymph node biopsy, focusing on the transition from routine dissection to more targeted interventions.
6. Collaborate on Lymphedema Care: Explain to practitioners the multidisciplinary prevention and management of lymphedema, including physiologic surgical options and the role of physical therapy in long-term risk reduction.
7. Evaluate Transgender Screening Protocols: Identify appropriate breast cancer screening strategies for transgender patients, navigating the controversies surrounding hormonal impact on tissue and residual risk post-gender-affirming surgery.
8. Navigate Triple Negative Breast Cancer (TNBC): Describe the latest neoadjuvant and adjuvant systemic therapies for TNBC and how these treatments influence subsequent surgical and reconstructive planning.
9. Assess Emerging Technologies: Evaluate the role of artificial intelligence, liquid biopsy (ctDNA), and advanced imaging in the modern diagnosis and management of breast disease.
10. Analyze Socioeconomic Impacts: Recognize the effects of financial toxicity and healthcare disparities on patient access to innovative care and reconstructive options.

Early Bird Registration
NOW to June 30

Physician      $799
Resident or Fellow      $25
Physician Assistant      $519
Nurse Practitioner      $519
Nurse      $519
Allied Health Professional      $519
Physical Therapist or Occupational Therapist    $519
Medical Student        $25
Industry Professional                                              $900

Advance Registration
July 1 to November 5

Physician      $899
Resident or Fellow      $50
Physician Assistant      $619
Nurse Practitioner      $619
Nurse      $619
Allied Health Professional      $619
Physical Therapist or Occupational Therapist    $619
Medical Student        $50
Industry Professional                                              $1000

On-Site Registration
November 6 to November 8, 2026
Physician      $999
Resident or Fellow      $75
Physician Assistant      $719
Nurse Practitioner      $719
Nurse      $719
Allied Health Professional      $719
Physical Therapist or Occupational Therapist    $719
Medical Student        $75
Industry Professional     $1,100

Accreditation: In support of improving patient care, this activity has been planned and implemented by MedStar Health and Mt. Sinai. MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation: This activity was planned by and for the healthcare team, and learners will receive 18.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physicians: MedStar Health designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 18.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physical Therapists: An application will be submitted to the Maryland Board of Physical Therapy Examiners for continuing education credits. Once submitted, approval by the Board will be pending, however not guaranteed.

Omni Shoreham Hotel
2500 Calvert St NW, Washington, DC 20008
Room rate: $239 plus tax
Reservation line: 1-800-THE-OMNI
Reservation link: Click Here
Please reference Breast Cancer Coordinated Care (BC3)
Cutoff date: October 8, 2026

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Rend Al-Khalili, MD
Associate Professor, Radiology
MedStar Georgetown University Hospital
Washington, D.C.

David N. Anderson, MD
Assistant Professor, Surgery
Icahn School of Medicine at Mount Sinai
New York, NY

Erin P. Crane, MD
Director, Breast-Body Imaging Fellowship Program, Associate Professor, Radiology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Lucy M. De La Cruz, MD
Chief, Breast Surgery, Director, Ourisman Breast Center Director
MedStar Georgetown University Hospital
Washington, D.C.

Gabriel Del Corral, MD
Director, MedStar Center for Gender Affirmation, Professor, Plastic Surgery and Urologic Surgery
MedStar Plastic & Reconstructive Surgery, MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Kenneth L. Fan, MD
Scientific Director, Plastic and Reconstructive Surgery, Attending Plastic Surgeon, Associate Professor, 4th Year Clerkship Director
MedStar Health Research Institute, MedStar Plastic and Reconstructive Surgery, Georgetown University School of Medicine
Washington, D.C.

Claudine Isaacs, MD
Associate Director, Clinical Research, Professor, Medicine, and Oncology
Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Georgetown University
Washington, D.C.

Maureen McBeth, PT, MPT
Senior Manager Clinical Research Education
ImpediMed, Inc.
Ellicott City, MD

Lisa Newman, MD, MPH
Chief, Section of Breast Surgery
New York-Presbyterian, Weill Cornell Medical Center, Weill Cornell Medicine
New York, NY

Elisa R. Port, MD
Chief, Breast Surgery, Director, Dubin Breast Center & Center of Excellence for Breast Cancer, Professor, Surgery
Mount Sinai Health System, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai
New York, NY

Hani Sbitany, MD
Professor of Surgery, Division of Plastic and Reconstructive Surgery
Mount Sinai Medical Center
New York, NY

Jennifer D. Son, MD
Director, Breast Health Center, Assistant Professor of Surgery
MedStar Montgomery Medical Center, MedStar Georgetown School of Medicine
Washington, D.C.

Peter J. Taub, MD, MS
System Chief, Plastic and Maxillofacial Surgery, Alfred and Florence Gross Professor of Surgery, Professor, Surgery, Pediatrics, Dentistry, Neurosurgery, and Medical Education
Icahn School of Medicine at Mount Sinai
New York, NY

Amy Tiersten, MD
Clinical Director, Breast Medical Oncology, Professor, Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Jay C. Zeck, MD
Medical Director Laboratory Medicine, Associate Professor, Pathology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

To sign up as a sponsor or obtain additional information regarding support packages, please contact Elizabeth Romano at [email protected]

Past BC3 Exhibitors

3M Healthcare
Allergan Aesthetics an AbbVie company
AstraZeneca
Bimini Health Tech
Clarix Imaging
Daiichi Sankyo, Inc
Endomag
Exact Sciences
Hologic
Impedimed, Inc.
Integra LifeSciences
Kubtec Medical Imaging
Lilly
Masthead
Medical Micro Instruments
MedStar Health Physical Medicine & Rehabilitation
Mentor Worldwide LLC
Merit Oncology
Mitaka USA
Natera, Inc.
NOVARTIS
obp Surgical
Paxman USA Inc.
Perimeter Medical Imaging AI
Pfizer Oncology
PhaseOne Health
PreludeDx
Premier Surgical Network, Breast and General Surgery
Resensation by Axogen
RTI Surgical
Seagen
SIA
Synovi MCA
Tactile Medical
The Institute for Advanced Reconstruction
Videra Surgical
ViOptix, Inc.

This conference offers the opportunity to exhibit at the conference. For more information, please contact Elizabeth Romano at [email protected] 

MedStar Health is pleased to invite you to submit an abstract for presentation at the Breast Cancer Coordinated Care (BC3) 2026 conference. This is an excellent opportunity for you and your colleagues to share your latest work and research with world-renown experts in the field!

Abstracts will be reviewed and selected on the basis of their scientific merit and content quality. Submitted abstracts meeting the eligibility requirements will be considered for poster presentations on November 6 to 8, 2026. The top five (5) abstracts will also be selected to present orally during the Oral Abstract Poster Presentation Symposium on Friday, November 6.

We invite you to participate by submitting a 250-word abstract, which should describe work with relevance to Breast Cancer Coordinated Care.

All material presented in the abstract must be current, relevant and free from ethical bias. Company logos of the supporting company are prohibited on any part of the presentation. All abstracts received will be considered to be presented as POSTER ABSTRACTS during the conference.

Submission Deadline: Abstracts must be submitted by September 4, 2026.

Abstract Acceptance

• Acceptance notification will be sent via email by September 18.
• Abstracts are selected on the basis of scientific merit.
• Expenses associated with the presentation of an abstract are the responsibility of the presenter.
• At least one presenting/submitting author per abstract must be registered.

Abstract Presentation

Abstracts will be electronic posters which will be displayed on digital boards at the conference.
(No physical poster size is required.)

Please note the submitting author will receive all correspondence about the abstract so we advise that the submitting author is who you would prefer to receive all communication.

You may submit more than 1 abstract. However, presenters that are accepted for oral presentation will be permitted to give only 1 oral presentation.  Additional accepted abstracts will therefore be poster only.